CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
BUZZY(tm) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03509857
NCT03509857N/ACompleted
CompareCT.gov

Vibration Analgesia in Propofol Infusion During Anesthesia Induction

Montefiore Medical Center·interventional·Posted Apr 26, 2018·Updated Sep 27, 2022

In Brief

A clinical study evaluating BUZZY(tm) and No Intervention for Pain, Acute. Completed, enrolled 100 participants across 1 site.

Detailed Summary

In this study, the investigators seek to evaluate the role of vibration in the reduction of discomfort associated with painful stimulus associated with anesthesia induction. Through this study, the investigators hope to develop a comprehensive and cost-effective approach to minimize patient discomfort during anesthesia induction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Acute
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 26, 2018
Enrollment StartFeb 1, 2019
Primary CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 8.2 years ago

Interventions

BUZZY(tm)device

Risks associated with the BUZZY(tm) device The intervention group will receive vibration only, with application of the BUZZY device just proximal to the intravenous infusion site immediately before and during propofol infusion. There are no known risks for the use of the BUZZY(tm) device, which is registered as an FDA class III device ("therapeutic massager").

No Interventionother

No intervention